Charles Rhyee
Stock Analyst at TD Cowen
(0.95)
# 3,870
Out of 4,989 analysts
52
Total ratings
37.14%
Success rate
-10.83%
Average return
Main Sectors:
Stocks Rated by Charles Rhyee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Downgrades: Sell | $283 → $366 | $497.62 | -26.45% | 5 | Jul 23, 2025 | |
| ICLR ICON Public Limited Company | Downgrades: Hold | $254 → $157 | $168.93 | -7.06% | 4 | Apr 14, 2025 | |
| CAH Cardinal Health | Upgrades: Buy | $130 → $144 | $154.95 | -7.07% | 2 | Jan 8, 2025 | |
| CRL Charles River Laboratories International | Maintains: Hold | $203 → $227 | $148.08 | +53.30% | 5 | Nov 11, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $23 → $25 | $9.44 | +164.83% | 3 | Nov 11, 2024 | |
| TDOC Teladoc Health | Maintains: Hold | $9 → $8 | $8.33 | -3.96% | 6 | Oct 31, 2024 | |
| VEEV Veeva Systems | Maintains: Hold | $180 → $192 | $277.82 | -30.89% | 3 | Aug 29, 2024 | |
| GDRX GoodRx Holdings | Maintains: Buy | $14 → $16 | $4.04 | +296.53% | 7 | May 16, 2024 | |
| TALK Talkspace | Maintains: Outperform | $4 → $5 | $2.65 | +89.04% | 2 | May 3, 2023 | |
| AMWL American Well | Downgrades: Market Perform | $100 → $50 | $6.40 | +681.25% | 3 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $251 | $185.03 | +35.65% | 1 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $56 | $8.31 | +573.89% | 2 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $360 → $280 | $9.78 | +2,762.99% | 3 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $48 → $50 | $9.33 | +435.91% | 2 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $325 → $361 | $759.01 | -52.44% | 3 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $35 | $27.85 | +25.67% | 1 | Feb 13, 2018 |
Medpace Holdings
Jul 23, 2025
Downgrades: Sell
Price Target: $283 → $366
Current: $497.62
Upside: -26.45%
ICON Public Limited Company
Apr 14, 2025
Downgrades: Hold
Price Target: $254 → $157
Current: $168.93
Upside: -7.06%
Cardinal Health
Jan 8, 2025
Upgrades: Buy
Price Target: $130 → $144
Current: $154.95
Upside: -7.07%
Charles River Laboratories International
Nov 11, 2024
Maintains: Hold
Price Target: $203 → $227
Current: $148.08
Upside: +53.30%
Fortrea Holdings
Nov 11, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $9.44
Upside: +164.83%
Teladoc Health
Oct 31, 2024
Maintains: Hold
Price Target: $9 → $8
Current: $8.33
Upside: -3.96%
Veeva Systems
Aug 29, 2024
Maintains: Hold
Price Target: $180 → $192
Current: $277.82
Upside: -30.89%
GoodRx Holdings
May 16, 2024
Maintains: Buy
Price Target: $14 → $16
Current: $4.04
Upside: +296.53%
Talkspace
May 3, 2023
Maintains: Outperform
Price Target: $4 → $5
Current: $2.65
Upside: +89.04%
American Well
Mar 23, 2023
Downgrades: Market Perform
Price Target: $100 → $50
Current: $6.40
Upside: +681.25%
Dec 6, 2022
Initiates: Outperform
Price Target: $251
Current: $185.03
Upside: +35.65%
Oct 20, 2022
Maintains: Outperform
Price Target: $70 → $56
Current: $8.31
Upside: +573.89%
Aug 16, 2022
Maintains: Outperform
Price Target: $360 → $280
Current: $9.78
Upside: +2,762.99%
Jun 21, 2022
Maintains: Outperform
Price Target: $48 → $50
Current: $9.33
Upside: +435.91%
Apr 18, 2022
Maintains: Outperform
Price Target: $325 → $361
Current: $759.01
Upside: -52.44%
Feb 13, 2018
Initiates: Market Perform
Price Target: $35
Current: $27.85
Upside: +25.67%